Page 112 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 112

96    Assurance of sterility for sensitive combination products and materials


          its combination cannot be verified at the point of use. In addition to patient
          safety requirements, the health-care industry is faced with the need for in-
          creased efficiency and productivity in order to drive down costs. Carefully
          designed validation approaches along with reliable test methods, and process
          control tools enable leveraging of data that can dramatically reduce the costs
          of changes and keep them to a minimum.

          5.3.2  Package integrity and the limitations of sterility testing

          Sterility testing has been used in the past to verify the sterility of products
          but it only provides a false sense of security since the conclusions that can
          be drawn from sterility test data have significant limitations. Sterility testing
          can only detect microorganisms that are viable, but testing is dependent
          on culture media and growth conditions. Testing for all types of microor-
          ganisms and all conditions is impractical. In addition, the sterility tests are
          destructive, take days to complete and are prone to false positives. This often
          leads to inconclusive root cause analysis if results are positive for microbial
          growth. Most importantly, the low incident rates require extremely large
          sample sizes to generate meaningful conclusions for sterility. For example:
             Assume the hypothetical case where sterility testing is used for accepting
          or rejecting a batch of packaged sterile devices with a sterility assurance
                       −2
          level, SAL =10 . In this case, one item out of hundred from this batch
          would potentially be non-sterile, vs the normal objective of one in a mil-
          lion. With only one tested sample, the probability to accept that batch is
              −2
          1–10  or 99%. With two tested samples, the probability to accept the batch
                                 −2
                        −2
          would be (1−10 ) × (1–10 ) = 98%. We can deduct the following formula:
                                                   −2
             Probability to accept a batch with SAL = 10  with n samples tested for
                         −2 n
          sterility: p = (1–10 ) .
             Using this formula for 20 samples, the batch is accepted in 82% of the
          cases, with 50 samples accepted in 50% of the cases and with 300 samples
          the batch would still be accepted in 5% of the cases. The typical target of
                     −6
          a SAL of 10  would require far more samples. One can easily conclude
                              −6
                                                            −6 n
          that with a SAL of 10 , the equation will be: p = (1–10 )  and millions
          of samples will be required to achieve similar confidence. Obviously, the
          practicalities of manufacturing millions of samples to destructively test them
          are prohibitive.
          5.3.3  Test methods

          Test methods are the cornerstone of all validation. An accurate and reli-
          able method to assess the output is required to make informed decisions.
   107   108   109   110   111   112   113   114   115   116   117